Uniseed is Australia’s longest-running venture fund, operating at the Universities of Melbourne, Queensland, Sydney & New South Wales, and the CSIRO, with investment capital provided by these research organisations and investment partners.
We are a unique commercialisation fund helping researchers from our partner research organisations turn their ideas into products and services. We support innovations that solve market problems and create a positive impact for our community. Uniseed invests over a broad range of technology sectors and has exited ten investments, to date.
We are a unique commercialisation fund helping researchers from our partner research organisations turn their ideas into products and services. We support innovations that solve market problems and create a positive impact for our community. Uniseed invests over a broad range of technology sectors and has exited ten investments, to date.
Location: Australia, Queensland, Brisbane City
Employees: 1-10
Founded date: 2000
Investment Type: Venture Capital
Portfolio 5
| Date | Name | Website | Total Raised | Location |
| 03.03.2026 | PlasmaLeap | plasmaleap.com | $19.58M | Australia |
| 17.12.2025 | Ferronova | ferronova.com.au | $13.71M | Australia |
| 22.10.2025 | Ena Respir... | enarespiratory.com | $51.4M | Australia |
| 26.09.2025 | Morse Micr... | morsemicro.com | $260.94M | Australia |
| 11.04.2022 | UniSuper | unisuper.com.au | $75M | Australia,... |
Mentions in press and media 14
| Date | Title | Description |
| 05.03.2026 | Green Chemical Breakthrough: PlasmaLeap Secures $20 Million for Zero-Emissions Future | PlasmaLeap Technologies secured $20 million in Series A funding. This capital accelerates zero-emissions fertilizer and sustainable fuel production. The initiative addresses global CO2 emissions from agriculture. It enables farmers to creat... |
| 03.03.2026 | PlasmaLeap Raises A$30 Million to Accelerate Zero-Emissions Production of Fertilisers and Fuels | Strategic and institutional investors including Yara International back PlasmaLeap to develop Green Fertiliser Technology Funding supports first-of-a-kind on-farm fertiliser deployments in Australia, and advances core technology for eFuels ... |
| 03.03.2026 | PlasmaLeap Technologies: A$30 Million Raised To Accelerate Zero-Emissions Fertilizer And Fuel Production | PlasmaLeap Technologies, an Australian clean-chemical technology company developing zero-emissions ammonia and nitric acid production systems, has secured almost A$30 million (US$20 million) in Series A funding to advance its decentralized ... |
| 17.12.2025 | Aussie medtech Ferronova raises another $6 million to advance image-guided cancer surgery | ADELAIDE, Australia, Dec. 17, 2025 /PRNewswire/ -- Australian company Ferronova has raised a further $6 million to progress the commercialisation of a novel nanoparticle image-guided surgery solution seeking to improve identification of can... |
| 27.10.2025 | ENA Respiratory Attracts US$22.4m (AU$34m) to Fund Phase II Clinical Studies of INNA-051 Nasal Spray Designed to Protect Against Symptomatic Viral Respiratory Infections | Melbourne, Australia, 20 October 2025 – ENA Respiratory, a clinical-stage pharmaceutical company developing antivirals that enhance the body’s natural viral defence mechanisms to minimise the impact of symptomatic viral respiratory infectio... |
| 22.10.2025 | ENA Respiratory Raises US$22.4M in Series B Financing | ENA Respiratory, a Melbourne, Australia-based clinical-stage pharmaceutical company developing antiviral host defense enhancers to minimize the impact of symptomatic viral respiratory infections, raised US$22.4m (AUD$34m) in Series B financ... |
| 26.09.2025 | Morse Micro: $59 Million Series C Closed For Wi-Fi HaLow Silicon Solutions | Morse Micro, a leader in providing Wi-Fi HaLow silicon solutions worldwide, has completed its Series C funding round, raising an impressive $59 million, which translates to $88 million in Australian currency. This significant investment was... |
| 05.09.2022 | $16m cash injection to progress first-in-class therapy for inflammation and fibrosis | Australian start-up OccuRx accelerates therapy development for diseases associated with inflammation and fibrosis – the cause of 45% of all deaths globally1 |
| 15.06.2021 | ENA Respiratory Advances COVID-19 Preventative Therapy through AU$32 Million Funding Round | Round jointly led by Brandon Capital and Minderoo Foundation with co-investment from Uniseed will support the clinical development of INNA-051 Company appoints President and Chief Scientific Officer of the COPD Foundation and respiratory th... |
| 15.06.2021 | ENA Respiratory Advances COVID-19 Preventative Therapy through AU$32 Million Fund Raise | ENA Respiratory, a biotechnology company developing a first-in-class nasal spray for the prevention of COVID-19 and other respiratory viral infections, announced today that it secured up to AU$32m investment and appointed Ruth Tal-Singer, P... |
Show more